Last updated: 23 July 2019 at 2:56pm EST

George Jue Net Worth




The estimated Net Worth of George Jue is at least $87.1 million dollars as of 2 March 2015. George Jue owns over 1,500 units of PDL Biopharma Inc stock worth over $87,027,204 and over the last 18 years George sold PDLI stock worth over $23,820.

George Jue PDLI stock SEC Form 4 insiders trading

George has made over 2 trades of the PDL Biopharma Inc stock since 2006, according to the Form 4 filled with the SEC. Most recently George sold 1,500 units of PDLI stock worth $23,820 on 2 March 2015.

The largest trade George's ever made was exercising 9,200 units of PDL Biopharma Inc stock on 8 November 2006 worth over $144,716. On average, George trades about 2,675 units every 759 days since 2006. As of 2 March 2015 George still owns at least 24,134 units of PDL Biopharma Inc stock.

You can see the complete history of George Jue stock trades at the bottom of the page.



What's George Jue's mailing address?

George's mailing address filed with the SEC is C/O PDL BIOPHARMA, INC., 34801 CAMPUS DRIVE, FREMONT, CA, 94555.

Insiders trading at PDL Biopharma Inc

Over the last 22 years, insiders at PDL Biopharma Inc have traded over $45,966,964 worth of PDL Biopharma Inc stock and bought 12,693,393 units worth $32,804,545 . The most active insiders traders include Point Capital L.P.O'shea Ro..., Faheem Hasnain et Laurence Jay Korn. On average, PDL Biopharma Inc executives and independent directors trade stock every 24 days with the average trade being worth of $245,074,578. The most recent stock trade was executed by Point Capital L.P.O'shea Ro... on 1 February 2021, trading 187,061 units of PDLI stock currently worth $383,475.



What does PDL Biopharma Inc do?



Complete history of George Jue stock trades at Ardelyx Inc et PDL Biopharma Inc

Initié
Trans.
Transaction
Prix ​​total
George Jue
Vice-président, opérations et Facilities
Vente $23,820
2 Mar 2015
George Jue
Vice-président, Fin et Corp. Controller
Exercice d'option $144,716
8 Nov 2006


PDL Biopharma Inc executives and stock owners

PDL Biopharma Inc executives and other stock owners filed with the SEC include: